Presentation is loading. Please wait.

Presentation is loading. Please wait.

The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients  Stephen J Elledge, Angelika Amon  Cancer.

Published byAna María Ríos Sosa Modified over 6 years ago

Similar presentations

Presentation on theme: "The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients  Stephen J Elledge, Angelika Amon  Cancer."— Presentation transcript:

1 The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients  Stephen J Elledge, Angelika Amon  Cancer Cell  Volume 1, Issue 2, Pages (March 2002) DOI: /S (02)

2 Figure 1 A schematic representation of the BRCA1 suppressor hypothesis as an explanation for breast and ovarian tissue specificity of cancer in BRCA1 heterozygous individuals See text for explanation. LOH: loss of heterozygosity. Colored circles represent cells of particular genotypes. Changes in circle color indicate a change in genotype. Cancer Cell 2002 1, DOI: ( /S (02) )

Download ppt "The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients  Stephen J Elledge, Angelika Amon  Cancer."

Similar presentations

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages 241-253 (March 2014) DOI: 10.1016/j.cell.2014.02.012 Copyright.

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Lessons from Hereditary Colorectal Cancer

Lessons from Hereditary Colorectal Cancer
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.

BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation Sari Kurki, Karita Peltonen, Leena Latonen,

Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation Sari Kurki, Karita Peltonen, Leena Latonen,
Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells Stephen J. Curtis, Kerstin W. Sinkevicius, Danan.

Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells Stephen J. Curtis, Kerstin W. Sinkevicius, Danan.
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: 10.1016/j.cell.2012.01.031 Copyright © 2012 Terms and Conditions Terms and Conditions.

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages 275-291 (March 2014) DOI: 10.1016/j.stem.2014.02.006.

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.

ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages 248-252 (April 2010) DOI: 10.1016/j.cmet.2010.03.008 Copyright © 2010.

Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
MiR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells Mathieu Neault, Frédérick A. Mallette, Stéphane Richard Cell.

MiR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells Mathieu Neault, Frédérick A. Mallette, Stéphane Richard Cell.
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages 1574-1594 (May 2003) DOI: 10.1016/S0016-5085(03)00376-7.

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Differential drug responses of circulating tumor cells within patient blood Andrew D. Hughes, Jocelyn R. Marshall, Eric Keller, John D. Powderly, Bryan.

Differential drug responses of circulating tumor cells within patient blood Andrew D. Hughes, Jocelyn R. Marshall, Eric Keller, John D. Powderly, Bryan.
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.
Tylosis esophageal cancer locus on chromosome 17q25

Tylosis esophageal cancer locus on chromosome 17q25
Pharmacogenetics and future drug development and delivery

Pharmacogenetics and future drug development and delivery
The benefits and harms of breast cancer screening

The benefits and harms of breast cancer screening
Illuminating the Properties of Prostate Luminal Progenitors

Illuminating the Properties of Prostate Luminal Progenitors
Cutaneous Cancer Stem Cells: β-Catenin Strikes Again

Cutaneous Cancer Stem Cells: β-Catenin Strikes Again
سرطان الثدي Breast Cancer

سرطان الثدي Breast Cancer
Intravascular Survival and Extravasation of Tumor Cells

Intravascular Survival and Extravasation of Tumor Cells

Similar presentations

Ads by Google